Aldehyde oxidase at the crossroad of metabolism and preclinical screening

References

• Acheampong AA, Chien DS, Lam S, Vekich S, Breau A, Usansky J, Harcourt D, Munk SA, Nguyen H, Garst M, et al. 1996. Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase. Xenobiotica. 26(10):1035–1055.
   PubMed Web of Science ®Google Scholar
• Akabane T, Gerst N, Masters JN, Tamura K. 2012. A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes. Xenobiotica. 42(9):863–871.
   PubMed Web of Science ®Google Scholar
• Akabane T, Tanaka K, Irie M, Terashita S, Teramura T. 2011. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans. Xenobiotica. 41(5):372–384.
   PubMed Web of Science ®Google Scholar
• Argikar UA, Potter PM, Hutzler JM, Marathe PH. 2016. Challenges and opportunities with non-CYP enzymes aldehyde oxidase, carboxylesterase, and UDP-glucuronosyltransferase: focus on reaction phenotyping and prediction of human clearance. Aaps J. 18(6):1391–1405.
   PubMed Web of Science ®Google Scholar
• Barr J, Jones J. 2011. Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions. Drug Metab Dispos. 39(12):2381–2386.
   PubMed Web of Science ®Google Scholar
• Barr JT, Jones JP. 2013. Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase. Drug Metab Dispos. 41(1):24–29.
   PubMed Web of Science ®Google Scholar
• Barr JT, Jones JP, Oberlies NH, Paine MF. 2015. Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance. Drug Metab Dispos. 43(1):34–41.
   PubMed Web of Science ®Google Scholar
• Beedham C. 1985. Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab Rev. 16(1–2):119–156.
   PubMed Web of Science ®Google Scholar
• Beedham C, Bruce S, Critchley D, Al-Tayib Y, Rance D. 1987. Species variation in hepatic aldehyde oxidase activity. Eur J Drug Metab Pharmacokinet. 12(4):307–310.
   PubMed Web of Science ®Google Scholar
• Beedham C, Bruce SE, Rance DJ. 1987. Tissue distribution of the molybdenum hydroxylases, aldehyde oxidase and xanthine oxidase, in male and female guinea pigs. Eur J Drug Metab Pharmacokinet. 12(4):303–306.
   PubMed Web of Science ®Google Scholar
• Beedham C, Critchley DJ, Rance DJ. 1995. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon. Arch Biochem Biophys. 319(2):481–490.
   PubMed Web of Science ®Google Scholar
• Beedham C, Miceli JJ, Obach RS. 2003. Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol. 23(3):229–232.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Hukkanen J, Jacob P. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield JE, London ED, Pogun S, editors. Nicotine psychopharmacology. Handbook of experimental pharmacology, vol. 192. Berlin (Heidelberg): Springer; p. 29–60.
   Google Scholar
• Calzi ML, Raviolo C, Ghibaudi E, de Gioia L, Salmona M, Cazzaniga G, Kurosaki M, Terao M, Garattini E. 1995. Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem. 270(52):31037–31045.
   PubMed Web of Science ®Google Scholar
• Chen S, Austin-Muttitt K, Zhang LH, Mullins JGL, Lau AJ. 2019. In vitro and in silico analyses of the inhibition of human aldehyde oxidase by bazedoxifene, lasofoxifene, and structural analogues. J Pharmacol Exp Ther. 370(3):75–86.
   Web of Science ®Google Scholar
• Choughule KV, Barnaba C, Joswig-Jones CA, Jones JP. 2014. In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase. Drug Metab Dispos. 42(8):1334–1340.
   PubMed Web of Science ®Google Scholar
• Choughule KV, Barr JT, Jones JP. 2013. Evaluation of Rhesus monkey and Guinea pig hepatic cytosol fractions as models for human aldehyde oxidase. Drug Metab Dispos. 41(10):1852–1858.
   PubMed Web of Science ®Google Scholar
• Choughule KV, Joswig-Jones CA, Jones JP. 2015. Interspecies differences in the metabolism of methotrexate: an insight into the active site differences between human and rabbit aldehyde oxidase. Biochem Pharmacol. 96(3):288–295.
   PubMed Web of Science ®Google Scholar
• Coelho C, Foti A, Hartmann T, Santos-Silva T, Leimkühler S, Romão MJ. 2015. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase. Nat Chem Biol. 11(10):779–783.
   PubMed Web of Science ®Google Scholar
• Coelho C, Mahro M, Trincão J, Carvalho AT, Ramos MJ, Terao M, Garattini E, Leimkühler S, Romão MJ. 2012. The first mammalian aldehyde oxidase crystal structure: insights into substrate specificity. J Biol Chem. 287(48):40690–40702.
   PubMed Web of Science ®Google Scholar
• Crouch RD, Blobaum AL, Felts AS, Conn PJ, Lindsley CW. 2017. Species-specific involvement of aldehyde oxidase and xanthine oxidase in the metabolism of the pyrimidine-containing mGlu5-negative allosteric modulator VU0424238 (Auglurant). Drug Metab Dispos. 45(12):1245–1259.
   PubMed Web of Science ®Google Scholar
• Cruciani G, Milani N, Benedetti P, Lepri S, Cesarini L, Baroni M, Spyrakis F, Tortorella S, Mosconi E, Goracci L. 2018. From experiments to a fast easy-to-use computational methodology to predict human aldehyde oxidase selectivity and metabolic reactions. J Med Chem. 61(1):360–371.
   PubMed Web of Science ®Google Scholar
• Cushnie TT, Lamb AJ. 2011. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents. 38(2):99–107.
   PubMed Web of Science ®Google Scholar
• Dalvie D, Xiang C, Kang P, Zhou S. 2013. Interspecies variation in the metabolism of zoniporide by aldehyde oxidase. Xenobiotica. 43(5):399–408.
   PubMed Web of Science ®Google Scholar
• Dalvie D, Zhang C, Chen W, Smolarek T, Obach S, Loi C-M. 2010. Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences. Drug Metab Dispos. 38(4):641–654.
   PubMed Web of Science ®Google Scholar
• Dalvie DK, Sun H, Kang P, Xiang C, Hu Q, Jiang Y. 2012. Effect of structural variation on aldehyde oxidase catalyzed oxidation of zoniporide. Drug Metab Dispos. 40(8):1575–1587.
   PubMed Web of Science ®Google Scholar
• Diamond S, Boer J, Maduskuie T, Falahatpisheh N, Li Y, Yeleswaram S. 2010. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications. Drug Metab Dispos. 38(8):1277–1285.
   PubMed Web of Science ®Google Scholar
• Dick RA, Kanne DB, Casida JE. 2006. Substrate specificity of rabbit aldehyde oxidase for nitroguanidine and nitromethylene neonicotinoid insecticides. Chem Res Toxicol. 19(1):38–43.
   PubMed Web of Science ®Google Scholar
• Dittrich C, Greim G, Borner M, Weigang-Köhler K, Huisman H, Amelsberg A, Ehret A, Wanders J, Hanauske A, Fumoleau P. 2002. Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration. Eur J Cancer. 38(8):1072–1080.
   PubMed Web of Science ®Google Scholar
• Eghbaliferiz S, Iranshahi M. 2016. Prooxidant activity of polyphenols, flavonoids, anthocyanins and carotenoids: updated review of mechanisms and catalyzing metals. Phytother Res. 30(9):1379–1391.
   PubMed Web of Science ®Google Scholar
• Ferreira P, Cerqueira N, Coelho C, Fernandes PA, Romao MJ, Ramos MJ. 2019. New insights about the monomer and homodimer structures of the human AOX1. Phys Chem Chem Phys. 21(25):13545–13554.
   PubMed Web of Science ®Google Scholar
• Fu C, Di L, Han X, Soderstrom C, Snyder M, Troutman MD, Obach RS, Zhang H. 2013. Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative characterization of AOX1 expression level and activity relationship. Drug Metab Dispos. 41(10):1797–1804.
   PubMed Web of Science ®Google Scholar
• Garattini E, Fratelli M, Terao M. 2008. Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol Life Sci. 65(7–8):1019–1048.
   PubMed Web of Science ®Google Scholar
• Garattini E, Fratelli M, Terao M. 2009. The mammalian aldehyde oxidase gene family. Hum Genomics. 4(2):119–130.
   PubMedGoogle Scholar
• Garattini E, Mendel R, Romão MJ, Wright R, Terao M. 2003. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J. 372(1):15–32.
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. 2011. Increasing recognition of the importance of aldehyde oxidase in drug development and discovery. Drug Metab Rev. 43(3):374–386.
   PubMed Web of Science ®Google Scholar
• Garattini E, Terao M. 2013. Aldehyde oxidase and its importance in novel drug discovery: present and future challenges. Expert Opin Drug Dis. 8(6):641–654.
   PubMed Web of Science ®Google Scholar
• Ghaffari T, Nouri M, Saei AA, Rashidi M-R. 2012. Aldehyde and xanthine oxidase activities in tissues of streptozotocin-induced diabetic rats: effects of vitamin E and selenium supplementation. Biol Trace Elem Res. 147(1–3):217–225.
   PubMed Web of Science ®Google Scholar
• Hamzeh-Mivehroud M, Rahmani S, Feizi MA, Dastmalchi S, Rashidi MR. 2014. In vitro and in silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition. Arch Pharm (Weinheim)). 347(10):738–747.
   PubMed Web of Science ®Google Scholar
• Hamzeh-Mivehroud M, Rahmani S, Rashidi MR, Dastmalchi S. 2016. Structural features of guinea pig aldehyde oxidase inhibitory activities of flavonoids explored using QSAR and molecular modeling studies. Med Chem Res. 25(12):2773–2786.
   Web of Science ®Google Scholar
• Hamzeh-Mivehroud M, Rahmani S, Rashidi MR, Hosseinpour Feizi MA, Dastmalchi S. 2013. Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids. Xenobiotica. 43(8):661–670.
   PubMed Web of Science ®Google Scholar
• Hartmann T, Terao M, Garattini E, Teutloff C, Alfaro JF, Jones JP, Leimkuhler S. 2012. The impact of single nucleotide polymorphisms on human aldehyde oxidase. Drug Metab Dispos. 40(5):856–864.
   PubMed Web of Science ®Google Scholar
• Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G, et al. 2017. Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo. Oncol Rep. 38(2):819–828.
   PubMed Web of Science ®Google Scholar
• Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. 2006. Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sci. 79(20):1944–1955.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Cerny MA, Yang Y-S, Asher C, Wong D, Frederick K, Gilpin K. 2014. Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382. Drug Metab Dispos. 42(10):1751–1760.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Obach RS, Dalvie D, Zientek MA. 2013. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opin Drug Metab Toxicol. 9(2):153–168.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Yang Y-S, Albaugh D, Fullenwider CL, Schmenk J, Fisher MB. 2012. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes. Drug Metab Dispos. 40(2):267–275.
   PubMed Web of Science ®Google Scholar
• Inoue K, Mizuo H, Kawaguchi S, Fukuda K, Kusano K, Yoshimura T. 2014. Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase. Drug Metab Dispos. 42(8):1326–1333.
   PubMed Web of Science ®Google Scholar
• Jin F, Robeson M, Zhou H, Moyer C, Wilbert S, Murray B, Ramanathan S. 2015. Clinical drug interaction profile of idelalisib in healthy subjects. J Clin Pharmacol. 55(8):909–919.
   PubMed Web of Science ®Google Scholar
• Jones JP, Korzekwa KR. 2013. Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase. Mol Pharm. 10(4):1262–1268.
   PubMed Web of Science ®Google Scholar
• Jordan CG, Rashidi MR, Laljee H, Clarke SE, Brown JE, Beedham C. 1999. Aldehyde oxidase‐catalysed oxidation of methotrexate in the liver of guinea‐pig, rabbit and man. J Pharm Pharmacol. 51(4):411–418.
   PubMed Web of Science ®Google Scholar
• Jung M, Bu SY, Tak K-H, Park J-E, Kim E. 2013. Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer. Nutr Res Pract. 7(6):439–445.
   PubMed Web of Science ®Google Scholar
• Kai H, Obuchi M, Yoshida H, Watanabe W, Tsutsumi S, Park YK, Matsuno K, Yasukawa K, Kurokawa M. 2014. In vitro and in vivo anti-influenza virus activities of flavonoids and related compounds as components of Brazilian propolis (AF-08). J Funct Foods. 8:214–223.
   Web of Science ®Google Scholar
• Kandaswami C, Middleton E. 1994. Free radical scavenging and antioxidant activity of plant flavonoids. In: Armstrong D, editor. Free radicals in diagnostic medicine. Boston (MA): Springer; p. 351–376.
   Google Scholar
• Kaul TN, Middleton E, Jr, Ogra PL. 1985. Antiviral effect of flavonoids on human viruses. J Med Virol. 15(1):71–79.
   PubMed Web of Science ®Google Scholar
• Kaye B, Offerman J, Reid J, Elliott H, Hillis W. 1984. A species difference in the presystemic metabolism of carbazeran in dog and man. Xenobiotica. 14(12):935–945.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Kim C-W, Jeon S-Y, Go R-E, Hwang K-A, Choi K-C. 2014. Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models. Lab Anim Res. 30(4):143–150.
   PubMedGoogle Scholar
• Kitamura S, Nakatani K, Ohashi K, Sugihara K, Hosokawa R, Akagawa Y, Ohta S. 2001. Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver. Biol Pharm Bull. 24(7):856–859.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Nitta K, Tayama Y, Tanoue C, Sugihara K, Inoue T, Horie T, Ohta S. 2008. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos. 36(7):1202–1205.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Sugihara K, Nakatani K, Ohta S, Ohhara T, Ninomiya S, Green CE, Tyson CA. 1999. Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life. 48(6):607–611.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Sugihara K, Ohta S. 2006. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet. 21(2):83–98.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Suzuki T, Kadota T, Yoshida M, Ohashi K, Ohta S. 2003. In vitro metabolism of fenthion and fenthion sulfoxide by liver preparations of sea bream, goldfish, and rats. Drug Metab Dispos. 31(2):179–186.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Tatsumi K. 1984a. Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem Biophys Res Commun. 120(2):602–606.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Tatsumi K. 1984b. Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase. Biochem Biophys Res Commun. 121(3):749–754.
   PubMed Web of Science ®Google Scholar
• Klecker RW, Cysyk RL, Collins JM. 2006. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors. Bioorg Med Chem. 14(1):62–66.
   PubMed Web of Science ®Google Scholar
• Krenitsky TA, Hall WW, de Miranda P, Beauchamp LM, Schaeffer HJ, Whiteman PD. 1984. 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir. Proc Natl Acad Sci USA. 81(10):3209–3213.
   PubMed Web of Science ®Google Scholar
• Kücükgöze G, Leimkühler S. 2018. Direct comparison of the four aldehyde oxidase enzymes present in mouse gives insight into their substrate specificities. PLoS One. 13(1):e0191819.
   PubMed Web of Science ®Google Scholar
• Lake B, Ball S, Kao J, Renwick A, Price R, Scatina J. 2002. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica. 32(10):835–847.
   PubMed Web of Science ®Google Scholar
• Lakshmanan M, Vaidyanathan C, Cama H. 1964. Oxidation of vitamin A1 aldehyde and vitamin A2 aldehyde to the corresponding acids by aldehyde oxidase from different species. Biochem J. 90(3):569–573.
   PubMed Web of Science ®Google Scholar
• Leoni C, Buratti FM, Testai E. 2008. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol Appl Pharmacol. 233(2):343–352.
   PubMed Web of Science ®Google Scholar
• Lepri S, Ceccarelli M, Milani N, Tortorella S, Cucco A, Valeri A, Goracci L, Brink A, Cruciani G. 2017. Structure-metabolism relationships in human-AOX: chemical insights from a large database of aza-aromatic and amide compounds. Proc Natl Acad Sci Usa. 114(16):E3178–E3187.
   PubMed Web of Science ®Google Scholar
• Li AC, Cui D, Yu E, Dobson K, Hellriegel ET, Robertson P. Jr 2018. Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate. Xenobiotica. 49(3):302–312.
   PubMed Web of Science ®Google Scholar
• Li YL, Guo H, Zhao YQ, Li AF, Ren YQ, Zhang JW. 2017. Quercetin protects neuronal cells from oxidative stress and cognitive degradation induced by amyloid β-peptide treatment. Mol Med Report. 16(2):1573–1577.
   PubMed Web of Science ®Google Scholar
• Maeda K, Ohno T, Igarashi S, Yoshimura T, Yamashiro K, Sakai M. 2012. Aldehyde oxidase 1 gene is regulated by Nrf2 pathway. Gene. 505(2):374–378.
   PubMed Web of Science ®Google Scholar
• Mahro M, Coelho C, Trincão J, Rodrigues D, Terao M, Garattini E, Saggu M, Lendzian F, Hildebrandt P, Romão MJ, et al. 2011. Characterization and crystallization of mouse aldehyde oxidase 3: from mouse liver to Escherichia coli heterologous protein expression. Drug Metab Dispos. 39(10):1939–1945.
   PubMed Web of Science ®Google Scholar
• Manevski N, Balavenkatraman KK, Bertschi B, Swart P, Walles M, Camenisch G, Schiller H, Kretz O, Ling B, Wettstein R, et al. 2014. Aldehyde oxidase activity in fresh human skin. Drug Metab Dispos. 42(12):2049–2057.
   PubMed Web of Science ®Google Scholar
• Mcdaniel HG, Podgainy H, Bressler R. 1969. The metabolism of tolbutamide in rat liver. J Pharmacol Exp Ther. 167(1):91–97.
   PubMed Web of Science ®Google Scholar
• Mendel RR. 2009. Cell biology of molybdenum. Biofactors. 35(5):429–434.
   PubMed Web of Science ®Google Scholar
• Merrill AH, Henderson JM. 1990. Vitamin B6 metabolism by human livera. Ann N Y Acad Sci. 585(1):110–117.
   PubMed Web of Science ®Google Scholar
• Montefiori M, Jørgensen FS, Olsen L. 2017. Aldehyde oxidase: reaction mechanism and prediction of site of metabolism. Acs Omega. 2(8):4237–4244.
   PubMed Web of Science ®Google Scholar
• Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Hada T. 2001. Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining. Histol Histopathol. 16(3):745–753.
   PubMed Web of Science ®Google Scholar
• Moriwaki Y, Yamamoto T, Yamaguchi K, Takahashi S, Higashino K. 1996. Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies. Histochem Cell Biol. 105(1):71–79.
   PubMed Web of Science ®Google Scholar
• Mota C, Coelho C, Leimkühler S, Garattini E, Terao M, Santos-Silva T, Romão MJ. 2018. Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics. Coord Chem Rev. 368:35–59.
   Web of Science ®Google Scholar
• Ni J, Rowe J, Heidelbaugh T, Sinha S, Acheampong A. 2007. Characterization of benzimidazole and other oxidative and conjugative metabolites of brimonidine in vitro and in rats in vivo using on-line HID exchange LC-MS/MS and stable-isotope tracer techniques. Xenobiotica. 37(2):205–220.
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen PA. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 74(4):418–425.
   PubMed Web of Science ®Google Scholar
• Nirogi R, Kandikere V, Palacharla RC, Bhyrapuneni G, Kanamarlapudi VB, Ponnamaneni RK, Manoharan AK. 2014. Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions. Xenobiotica. 44(3):197–204.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Naito S. 2006. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet. 21(5):357–374.
   PubMed Web of Science ®Google Scholar
• O’Hara F, Burns AC, Collins MR, Dalvie D, Ornelas MA, Vaz AD, Fujiwara Y, Baran PS. 2014. A simple litmus test for aldehyde oxidase metabolism of heteroarenes. J Med Chem. 57(4):1616–1620.
   PubMed Web of Science ®Google Scholar
• Obach RS. 2004. Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos. 32(1):89–97.
   PubMed Web of Science ®Google Scholar
• Obach RS, Huynh P, Allen MC, Beedham C. 2004. Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol. 44(1):7–19.
   PubMed Web of Science ®Google Scholar
• Ohkubo M, Sakiyama S, Fujimura S. 1983. Increase of nicotinamide methyltransferase and N1-methyl-nicotinamide oxidase activities in the livers of the rats administered alkylating agents. Cancer Lett. 21(2):175–181.
   PubMed Web of Science ®Google Scholar
• Paragas EM, Humphreys SC, Min J, Joswig-Jones CA, Jones JP. 2017. The two faces of aldehyde oxidase: oxidative and reductive transformations of 5-nitroquinoline. Biochem Pharmacol. 145:210–217.
   PubMed Web of Science ®Google Scholar
• Paragas EM, Humphreys SC, Min J, Joswig-Jones CA, Leimkuhler S, Jones JP. 2017. ecoAO: a simple system for the study of human aldehyde oxidases role in drug metabolism. ACS Omega. 2(8):4820–4827.
   PubMed Web of Science ®Google Scholar
• Pasetto S, Pardi V, Murata RM. 2014. Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. PLoS One. 9(12):e115323.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Dalvie D, Hu Q, Jones P, Obach RS, Tran T-D. 2010. Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem. 53(24):8441–8460.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Tran T-D, Jones P, Duckworth J, Howard M, Gardner I, Hyland R, Webster R, Wenham T, Bagal S, et al. 2012. Medicinal chemistry approaches to avoid aldehyde oxidase metabolism. Bioorg Med Chem Lett. 22(8):2856–2860.
   PubMed Web of Science ®Google Scholar
• Rashidi MR, Beedham C, Smith JS, Davaran S. 2007. In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase. Drug Metab Pharmacokinet. 22(4):299–306.
   PubMed Web of Science ®Google Scholar
• Rashidi MR, Smith JA, Clarke SE, Beedham C. 1997. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metab Dispos. 25(7):805–813.
   PubMed Web of Science ®Google Scholar
• Relling MV, Lin JS, Ayers GD, Evans WE. 1992. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther. 52(6):643–658.
   PubMed Web of Science ®Google Scholar
• Rivera SP, Choi HH, Chapman B, Whitekus MJ, Terao M, Garattini E, Hankinson O. 2005. Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes. Toxicology. 207(3):401–409.
   PubMed Web of Science ®Google Scholar
• Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P. 1998. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver. Biochem Pharmacol. 56(1):15–23.
   PubMed Web of Science ®Google Scholar
• Sahi J, Khan KK, Black CB. 2008. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. Drug Metab Lett. 2(3):176–183.
   PubMedGoogle Scholar
• Sanoh S, Tayama Y, Sugihara K, Kitamura S, Ohta S. 2015. Significance of aldehyde oxidase during drug development: effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metab Pharmacokinet. 30(1):52–63.
   PubMed Web of Science ®Google Scholar
• Seeley TL, Mather PB, Holmes RS. 1984. Electrophoretic analyses of alcohol dehydrogenase, aldehyde dehydrogenase, aldehyde reductase, aldehyde oxidase and xanthine oxidase from horse tissues. Comp Biochem Physiol, B. 78(1):131–139.
   PubMed Web of Science ®Google Scholar
• Shintani Y, Maruoka S, Gon Y, Koyama D, Yoshida A, Kozu Y, Kuroda K, Takeshita I, Tsuboi E, Soda K, et al. 2015. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates airway epithelial barrier integrity. Allergol Int. 64:S54–S63.
   PubMed Web of Science ®Google Scholar
• Siah M, Farzaei MH, Ashrafi-Kooshk MR, Adibi H, Arab SS, Rashidi MR, Khodarahmi R. 2016. Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: an in vitro study. Bioorg Chem. 64:74–84.
   PubMed Web of Science ®Google Scholar
• Stanulović M, Chaykin S. 1971. Aldehyde oxidase: catalysis of the oxidation of N 1 -methylnicotinamide and pyridoxal. Arch Biochem Biophys. 145(1):27–34.
   PubMed Web of Science ®Google Scholar
• Stanulovic M, Jeremic V, Leskovac V, Chaykin S. 1976. New pathway of conversion of pyridoxal to 4-pyridoxic acid. Enzyme. 21(4):357–369.
   PubMedGoogle Scholar
• Strelevitz TJ, Orozco CC, Obach RS. 2012. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance. Drug Metab Dispos. 40(7):1441–1448.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Kitamura S, Tatsumi K. 1996. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab Dispos. 24(2):199–202.
   PubMed Web of Science ®Google Scholar
• Takaoka N, Sanoh S, Okuda K, Kotake Y, Sugahara G, Yanagi A, Ishida Y, Tateno C, Tayama Y, Sugihara K, et al. 2018. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions. Biochem Pharmacol. 154:28–38.
   PubMed Web of Science ®Google Scholar
• Tayama Y, Moriyasu A, Sugihara K, Ohta S, Kitamura S. 2007. Developmental changes of aldehyde oxidase in postnatal rat liver. Drug Metab Pharmacokinet. 22(2):119–124.
   PubMed Web of Science ®Google Scholar
• Tayama Y, Sugihara K, Sanoh S, Miyake K, Kitamura S, Ohta S. 2012. Developmental changes of aldehyde oxidase activity and protein expression in human liver cytosol. Drug Metab Pharmacokinet. 27(5):543–547.
   PubMed Web of Science ®Google Scholar
• Tayama Y, Sugihara K, Sanoh S, Miyake K, Morita S, Kitamura S, Ohta S. 2011. Effect of tea beverages on aldehyde oxidase activity. Drug Metab Pharmacokinet. 26(1):94–101.
   PubMed Web of Science ®Google Scholar
• Taylor PW, Hamilton-Miller JM, Stapleton PD. 2005. Antimicrobial properties of green tea catechins. Food Sci Technol Bull. 2:71–81.
   PubMedGoogle Scholar
• Terao M, Barzago MM, Kurosaki M, Fratelli M, Bolis M, Borsotti A, Bigini P, Micotti E, Carli M, Invernizzi RW, et al. 2016. Mouse aldehyde-oxidase-4 controls diurnal rhythms, fat deposition and locomotor activity. Sci Rep. 6:30343.
   PubMed Web of Science ®Google Scholar
• Terao M, Kurosaki M, Barzago MM, Fratelli M, Bagnati R, Bastone A, Giudice C, Scanziani E, Mancuso A, Tiveron C, et al. 2009. Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: generation and characterization of a knockout mouse. Mol Cell Biol. 29(2):357–377.
   PubMed Web of Science ®Google Scholar
• Terao M, Romao MJ, Leimkuhler S, Bolis M, Fratelli M, Coelho C, Santos-Silva T, Garattini E. 2016. Structure and function of mammalian aldehyde oxidases. Arch Toxicol. 90(4):753–780.
   PubMed Web of Science ®Google Scholar
• Torres RA, Korzekwa KR, McMasters DR, Fandozzi CM, Jones JP. 2007. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase. J Med Chem. 50(19):4642–4647.
   PubMed Web of Science ®Google Scholar
• Wang L-S, Stoner GD. 2008. Anthocyanins and their role in cancer prevention. Cancer Lett. 269(2):281–290.
   PubMed Web of Science ®Google Scholar
• Whittlesea MC, Gorrod JW. 1993. The enzymology of the in–vitro oxidation of prolintane to oxoprolintane. J Clin Pharm Ther. 18(5):357–364.
   Web of Science ®Google Scholar
• Wilkinson DJ, Southall RL, Li M, Wright LM, Corfield LJ, Heeley TA, Bratby B, Mannu R, Johnson SL, Shaw V, et al. 2017. Minipig and human metabolism of aldehyde oxidase substrates: in vitro-in vivo comparisons. Aaps J. 19(4):1163–1174.
   PubMed Web of Science ®Google Scholar
• Wu C-C, Fang C-Y, Cheng Y-J, Hsu H-Y, Chou S-P, Huang S-Y, Tsai C-H, Chen J-Y. 2017. Inhibition of Epstein–Barr virus reactivation by the flavonoid apigenin. J Biomed Sci. 24(1):2.
   PubMed Web of Science ®Google Scholar
• Xiao J. 2017. Dietary flavonoid aglycones and their glycosides: which show better biological significance? Crit Rev Food Sci Nutr. 57(9):1874–1905.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li L, Wang Y, Xing J, Zhou L, Zhong D, Luo X, Jiang H, Chen K, Zheng M, et al. 2017. Aldehyde oxidase mediated metabolism in drug-like molecules: a combined computational and experimental study. J Med Chem. 60(7):2973–2982.
   PubMed Web of Science ®Google Scholar
• Yang CS, Ju J, Lu G, Xiao H, Hao X, Sang S, Lambert JD. 2008. Cancer prevention by tea and tea polyphenols. Asia Pac J Clin Nutr. 17:245–248.
   PubMed Web of Science ®Google Scholar
• Zetterberg C, Maltais F, Laitinen L, Liao S, Tsao H, Chakilam A, Hariparsad N. 2016. VX-509 (decernotinib)-mediated CYP3A time-dependent inhibition: an aldehyde oxidase metabolite as a perpetrator of drug–drug interactions. Drug Metab Dispos. 44(8):1286–1295.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Xiao W, Gao ZT, Yu ZT, Zhang J. 2018. Metabolism of c-met kinase inhibitors containing quinoline by aldehyde oxidase, electron donating, and steric hindrance effect. Drug Metab Dispos. 46(12):1847–1855.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu H, Weller P, Zheng M, Tao W, Wang J, Liao G, Monshouwer M, Peltz G. 2011. In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. Pharmacogenomics J. 11(1):15–24.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang P, Shehu AI, Lu J, Bi H, Ma X. 2018. Identification of novel pathways in idelalisib metabolism and bioactivation. Chem Res Toxicol. 31(7):548–555.
   PubMed Web of Science ®Google Scholar
• Zientek M, Jiang Y, Youdim K, Obach RS. 2010. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab Dispos. 38(8):1322–1327.
   PubMed Web of Science ®Google Scholar